Teva Shares Are Getting Obliterated Again After Vicious Investment Bank Downgrades
Teva Pharmaceutical Industries Ltd. (TEVA) stock tumbled Friday afternoon as Wall Street came down hard on the company. The stock closed at $20.60.
Credit Suisse analyst Vamil Divan downgraded the Israeli pharmaceutical company to "neutral" from "outperform."
Credit Suisse analyst Vamil Divan downgraded the Israeli pharmaceutical company to "neutral" from "outperform."